 |
|
Will Blood Transfusion Ever Be Safe Enough?
Harvey G. Klein, MD
JAMA. 2000;284:238-240.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Is blood transfusion safe, or is blood one of the most dangerous drugs in the physician's therapeutic armamentarium? The articles by Glynn et al1 and Ling et al2 in this issue of THE JOURNAL embody the quintessential paradox of blood transfusion: blood is safer than ever, but the usual notions of safety do not necessarily apply where transfusion is concerned.1-2 Perhaps it is the mythical and spiritual significance that has been attached to blood by many cultures, or perhaps the devastation inflicted on the recipients of blood infected with the human immunodeficiency virus (HIV). Whatever the reason, blood seems to have gained a singular status—simultaneously feared and revered. Developed countries have come to demand absolute freedom from transfusion-transmitted infection, while simultaneously conceding that zero-risk transfusion is unlikely to ever be achieved.
Blood collection in the United States depends on a system of safeguards to reduce the . . . [Full Text of this Article]
Author Affiliation: Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Md.
RELATED ARTICLES
Failure of Routine HIV-1 Tests in a Case Involving Transmission With Preseroconversion Blood Components During the Infectious Window Period
Ai Ee Ling, Kenneth E. Robbins, Teresa M. Brown, Valerie Dunmire, Su Yun Se Thoe, Sin-Yew Wong, Yee Sin Leo, Diana Teo, James Gallarda, Bruce Phelps, Mary E. Chamberland, Michael P. Busch, Thomas M. Folks, and Marcia L. Kalish
JAMA. 2000;284(2):210-214.
ABSTRACT
| FULL TEXT
Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996
Simone A. Glynn, Steven H. Kleinman, George B Schreiber, Michael P. Busch, David J. Wright, James W. Smith, Catharie C. Nass, Alan E. Williams, and for the Retrovirus Epidemiology Donor Study
JAMA. 2000;284(2):229-235.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A New Era in the Ethics of Human Embryonic Stem Cell Research
Lo et al.
Stem Cells 2005;23:1454-1459.
ABSTRACT
| FULL TEXT
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial
McCullough et al.
Blood 2004;104:1534-1541.
ABSTRACT
| FULL TEXT
Will we ever know if leukoreduction of red blood cells should be performed?/Saurons-nous un jour s'il faut proceder a la reduction leucocytaire des culots globulaires ?
Carson and Berlin
Canadian J. Anesthesia 2004;51:407-410.
FULL TEXT
Is Leukoreduction of Blood Components for Everyone?
Corwin and AuBuchon
JAMA 2003;289:1993-1995.
FULL TEXT
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial
van Rhenen et al.
Blood 2003;101:2426-2433.
ABSTRACT
| FULL TEXT
Current and Emerging Infectious Risks of Blood Transfusions
Busch et al.
JAMA 2003;289:959-962.
FULL TEXT
THE ASSOCIATION OF HEALTH-CARE USE AND HEPATITIS C VIRUS INFECTION IN A RANDOM SAMPLE OF URBAN SLUM COMMUNITY RESIDENTS IN SOUTHERN INDIA
MARX et al.
Am J Trop Med Hyg 2003;68:258-262.
ABSTRACT
| FULL TEXT
Should Patients in Intensive Care Units Receive Erythropoietin?
Carson
JAMA 2002;288:2884-2886.
FULL TEXT
HIV Seroconversion Resulting from Insensitive Blood Screening Measures
JWatch Emergency Med. 2000;2000:1-1.
FULL TEXT
Safeguarding Blood Against HIV: When Is Enough Enough?
JWatch General 2000;2000:1-1.
FULL TEXT
|
